Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE27.8500
- TODAY'S CHANGE (%)-0.1500 (-0.5357%)
- Bid / Lots27.8500/ 7
- Ask / Lots27.8600/ 9
- Open / Previous Close28.0100 / 28.0000
- Day Range
- 52 Week Range
- Volume1,775,023
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 43482 | 28.01 |
| 09:34 ET | 4532 | 27.95 |
| 09:36 ET | 2479 | 28 |
| 09:38 ET | 17438 | 28.03 |
| 09:39 ET | 4800 | 28.05 |
| 09:41 ET | 2100 | 28.075 |
| 09:43 ET | 1872 | 28.085 |
| 09:45 ET | 5939 | 28.13 |
| 09:48 ET | 4607 | 28.114 |
| 09:50 ET | 2042 | 28.11 |
| 09:52 ET | 10572 | 28.105 |
| 09:54 ET | 1800 | 28.105 |
| 09:56 ET | 2449 | 28.065 |
| 09:57 ET | 1305 | 28.075 |
| 09:59 ET | 2917 | 28.03 |
| 10:01 ET | 10537 | 27.985 |
| 10:03 ET | 7127 | 27.97 |
| 10:06 ET | 1760 | 27.965 |
| 10:08 ET | 4609 | 27.965 |
| 10:10 ET | 8784 | 27.96 |
| 10:12 ET | 5006 | 27.978 |
| 10:14 ET | 3108 | 27.995 |
| 10:15 ET | 6775 | 28.015 |
| 10:17 ET | 6041 | 28.055 |
| 10:19 ET | 7274 | 28.065 |
| 10:21 ET | 3299 | 28.071 |
| 10:24 ET | 1616 | 28.095 |
| 10:26 ET | 10007 | 28.065 |
| 10:28 ET | 257617 | 28.065 |
| 10:30 ET | 919 | 28.06 |
| 10:32 ET | 6089 | 28.04 |
| 10:33 ET | 3658 | 28.005 |
| 10:35 ET | 10855 | 27.995 |
| 10:37 ET | 11822 | 27.99 |
| 10:39 ET | 10257 | 27.955 |
| 10:42 ET | 14285 | 27.975 |
| 10:44 ET | 12160 | 27.975 |
| 10:46 ET | 3954 | 27.985 |
| 10:48 ET | 4320 | 27.95 |
| 10:50 ET | 4929 | 27.92 |
| 10:51 ET | 6100 | 27.965 |
| 10:53 ET | 21547 | 28.055 |
| 10:55 ET | 3013 | 28.075 |
| 10:57 ET | 2660 | 28.075 |
| 11:00 ET | 5944 | 28.075 |
| 11:02 ET | 3818 | 28.055 |
| 11:04 ET | 3259 | 28.06 |
| 11:06 ET | 5478 | 28.065 |
| 11:08 ET | 1616 | 28.065 |
| 11:09 ET | 3683 | 28.085 |
| 11:11 ET | 3798 | 28.085 |
| 11:13 ET | 2717 | 28.095 |
| 11:15 ET | 5006 | 28.08 |
| 11:18 ET | 5171 | 28.065 |
| 11:20 ET | 46508 | 28.025 |
| 11:22 ET | 3825 | 28.02 |
| 11:24 ET | 9392 | 27.985 |
| 11:26 ET | 16249 | 27.985 |
| 11:27 ET | 8410 | 27.985 |
| 11:29 ET | 9861 | 27.96 |
| 11:31 ET | 30993 | 27.995 |
| 11:33 ET | 9926 | 28.025 |
| 11:36 ET | 4099 | 28.035 |
| 11:38 ET | 7560 | 28.035 |
| 11:40 ET | 4205 | 28.055 |
| 11:42 ET | 6180 | 28.035 |
| 11:44 ET | 2014 | 28.03 |
| 11:45 ET | 2725 | 28.035 |
| 11:47 ET | 5368 | 28.026 |
| 11:49 ET | 7687 | 28.03 |
| 11:51 ET | 5928 | 28.035 |
| 11:54 ET | 4090 | 28.045 |
| 11:56 ET | 6719 | 28.075 |
| 11:58 ET | 3271 | 28.055 |
| 12:00 ET | 5472 | 28.01 |
| 12:02 ET | 2572 | 28.005 |
| 12:03 ET | 6146 | 28.05 |
| 12:05 ET | 2525 | 28.04 |
| 12:07 ET | 3896 | 28.02 |
| 12:09 ET | 1396 | 28.01 |
| 12:12 ET | 1202 | 27.991 |
| 12:14 ET | 1218 | 27.99 |
| 12:16 ET | 4986 | 27.99 |
| 12:18 ET | 7822 | 27.985 |
| 12:20 ET | 21421 | 28.045 |
| 12:21 ET | 63144 | 27.99 |
| 12:23 ET | 2400 | 27.965 |
| 12:25 ET | 4149 | 27.975 |
| 12:27 ET | 9455 | 28.005 |
| 12:30 ET | 4537 | 27.965 |
| 12:32 ET | 2500 | 27.935 |
| 12:34 ET | 3227 | 27.895 |
| 12:36 ET | 2303 | 27.905 |
| 12:38 ET | 3423 | 27.915 |
| 12:39 ET | 6465 | 27.895 |
| 12:41 ET | 3147 | 27.885 |
| 12:43 ET | 16166 | 27.88 |
| 12:45 ET | 3260 | 27.9 |
| 12:48 ET | 3898 | 27.905 |
| 12:50 ET | 2200 | 27.92 |
| 12:52 ET | 3566 | 27.925 |
| 12:54 ET | 4504 | 27.905 |
| 12:56 ET | 107920 | 27.905 |
| 12:57 ET | 1900 | 27.905 |
| 12:59 ET | 2640 | 27.905 |
| 01:01 ET | 19860 | 27.875 |
| 01:03 ET | 8681 | 27.895 |
| 01:06 ET | 6600 | 27.895 |
| 01:08 ET | 8587 | 27.89 |
| 01:10 ET | 3146 | 27.88 |
| 01:12 ET | 8858 | 27.895 |
| 01:14 ET | 6895 | 27.905 |
| 01:15 ET | 6722 | 27.91 |
| 01:17 ET | 7935 | 27.895 |
| 01:19 ET | 4667 | 27.86 |
| 01:21 ET | 4719 | 27.8725 |
| 01:24 ET | 888 | 27.88 |
| 01:26 ET | 3616 | 27.85 |
| 01:28 ET | 8583 | 27.87 |
| 01:30 ET | 4064 | 27.855 |
| 01:32 ET | 7384 | 27.87 |
| 01:33 ET | 1252 | 27.875 |
| 01:35 ET | 2800 | 27.91 |
| 01:37 ET | 4137 | 27.895 |
| 01:39 ET | 1308 | 27.88 |
| 01:42 ET | 1318 | 27.88 |
| 01:44 ET | 2233 | 27.88 |
| 01:46 ET | 3644 | 27.865 |
| 01:48 ET | 1932 | 27.88 |
| 01:50 ET | 2373 | 27.895 |
| 01:51 ET | 1499 | 27.895 |
| 01:53 ET | 6417 | 27.905 |
| 01:55 ET | 16312 | 27.915 |
| 01:57 ET | 733 | 27.915 |
| 02:00 ET | 2917 | 27.9258 |
| 02:02 ET | 3466 | 27.92 |
| 02:04 ET | 4624 | 27.895 |
| 02:06 ET | 9454 | 27.87 |
| 02:08 ET | 4618 | 27.87 |
| 02:09 ET | 8295 | 27.87 |
| 02:11 ET | 2080 | 27.87 |
| 02:13 ET | 6059 | 27.86 |
| 02:15 ET | 15541 | 27.855 |
| 02:18 ET | 5415 | 27.88 |
| 02:20 ET | 2490 | 27.88 |
| 02:22 ET | 1797 | 27.885 |
| 02:24 ET | 7267 | 27.92 |
| 02:26 ET | 1619 | 27.93 |
| 02:27 ET | 3011 | 27.9328 |
| 02:29 ET | 5376 | 27.93 |
| 02:31 ET | 1817 | 27.935 |
| 02:33 ET | 2386 | 27.9297 |
| 02:36 ET | 4004 | 27.915 |
| 02:38 ET | 991 | 27.919 |
| 02:40 ET | 2096 | 27.915 |
| 02:42 ET | 3759 | 27.915 |
| 02:44 ET | 2348 | 27.915 |
| 02:45 ET | 11149 | 27.91 |
| 02:47 ET | 2816 | 27.885 |
| 02:49 ET | 6800 | 27.89 |
| 02:51 ET | 1509 | 27.885 |
| 02:54 ET | 2981 | 27.885 |
| 02:56 ET | 3982 | 27.88 |
| 02:58 ET | 1810 | 27.88 |
| 03:00 ET | 3425 | 27.875 |
| 03:02 ET | 5855 | 27.895 |
| 03:03 ET | 4051 | 27.9 |
| 03:05 ET | 1299 | 27.895 |
| 03:07 ET | 2538 | 27.895 |
| 03:09 ET | 2847 | 27.92 |
| 03:12 ET | 3639 | 27.93 |
| 03:14 ET | 2735 | 27.925 |
| 03:16 ET | 1600 | 27.925 |
| 03:18 ET | 6594 | 27.895 |
| 03:20 ET | 6073 | 27.895 |
| 03:21 ET | 5782 | 27.885 |
| 03:23 ET | 12855 | 27.86 |
| 03:25 ET | 17602 | 27.86 |
| 03:27 ET | 2208 | 27.865 |
| 03:30 ET | 5267 | 27.865 |
| 03:32 ET | 3099 | 27.85 |
| 03:34 ET | 3937 | 27.85 |
May 13, 2024
Royalty Pharma to Present at Upcoming Investor Conferences, from 8:15AM ET on Monday May 13, 2024 by Dow Jones
8:15AM ET on Monday May 13, 2024 by Dow Jones
May 9, 2024
Royalty Pharma Reports First Quarter 2024 Results, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
7:00AM ET on Thursday May 09, 2024 by Dow Jones*DJ Royalty Pharma 1Q Net $5M >RPRX, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
7:00AM ET on Thursday May 09, 2024 by Dow JonesRoyalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones
6:45AM ET on Thursday May 09, 2024 by Dow JonesPress Release: Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones
6:45AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.9B | 15.6x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -12.0x | --- |
Catalent Inc | 10.1B | -8.5x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 22.7x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Roivant Sciences Ltd | 9.3B | 2.3x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.9B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.02% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.48 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.6x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | 14.2x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
